Measuring Clinically Significant Chemotherapy-Related Toxicities Using Medicare Claims From Cancer and Leukemia Group B (CALGB) Trial Participants
Medical Care - United States
doi 10.1097/mlr.0b013e31815cecc3
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)